New! Sign up for our free email newsletter.
Science News
from research organizations

Older patients with Crohn's disease benefit from new medications

Date:
March 20, 2019
Source:
Wiley
Summary:
Combining medications that suppress the immune system has been successful in treating young patients with Crohn's disease, but some physicians have been reluctant to use this strategy in older patients because of concerns about safety. Now a new study indicates that older patients can be safely and effectively treated with such combined immunosuppression as well.
Share:
FULL STORY

Combining medications that suppress the immune system has been successful in treating young patients with Crohn's disease, but some physicians have been reluctant to use this strategy in older patients because of concerns about safety. Now an Alimentary Pharmacology & Therapeutics study indicates that older patients can be safely and effectively treated with such combined immunosuppression as well.

Among the 1,981 patients in the study, 311 were aged 60 years or older (173 randomised to early combined immunosuppression and 138 to conventional management). Over 24 months, 10 percent of older patients developed Crohn's disease?related complications (6.4 percent of those in the combined immunosuppression group versus 14.5 percent of those in the conventional management group) and 14 patients died (3.5 percent versus 5.8 percent).

Among the patients who received combined immunosuppression in the study, older patients experienced remission of their disease to a similar extent as those aged under 60 years. There was also no increase in side effects from these medicines in older patients.

"It is important to treat aggressive Crohn's disease appropriately regardless of age," said lead author Dr. Siddharth Singh, of the University of California San Diego. "This may include early step-up combination therapy of tumour necrosis factor-alpha antagonists with thiopurines, which is effective and safe even in older patients, rather than treating these patients with chronic or repeated courses of corticosteroids."


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Siddharth Singh, Larry W. Stitt, Guangyong Zou, Reena Khanna, Parambir S. Dulai, William J. Sandborn, Brian G. Feagan, Vipul Jairath. Early combined immunosuppression may be effective and safe in older patients with Crohn’s disease: post hoc analysis of REACT. Alimentary Pharmacology & Therapeutics, 2019; DOI: 10.1111/apt.15214

Cite This Page:

Wiley. "Older patients with Crohn's disease benefit from new medications." ScienceDaily. ScienceDaily, 20 March 2019. <www.sciencedaily.com/releases/2019/03/190320102036.htm>.
Wiley. (2019, March 20). Older patients with Crohn's disease benefit from new medications. ScienceDaily. Retrieved July 15, 2024 from www.sciencedaily.com/releases/2019/03/190320102036.htm
Wiley. "Older patients with Crohn's disease benefit from new medications." ScienceDaily. www.sciencedaily.com/releases/2019/03/190320102036.htm (accessed July 15, 2024).

Explore More

from ScienceDaily

RELATED STORIES